TY - JOUR
T1 - Dynamic temporal and spatial regulation of mu opioid receptor expression in primary afferent neurons following spinal nerve injury
AU - Lee, Chun Yi
AU - Perez, Federico M.
AU - Wang, Wei
AU - Guan, Xiaowei
AU - Zhao, Xiuli
AU - Fisher, Janet L.
AU - Guan, Yun
AU - Sweitzer, Sarah M.
AU - Raja, Srinivasa Naga
AU - Tao, Yuanxiang
N1 - Funding Information:
This work was supported by National Institutes of Health Grants ( NS26363 and NS058886 ), the Blaustein Pain Research Fund, and the Patrick C. Walsh Prostate Cancer Research Fund. The authors thank Claire Levine, MS, for editorial assistance.
PY - 2011/8
Y1 - 2011/8
N2 - Despite using prescribed pain medications, patients with neuropathic pain continue to experience moderate to severe pain. There is a growing recognition of a potent peripheral opioid analgesia in models of inflammatory and neuropathic pain. The goal of this study was to characterize the temporal and spatial expression of mu opioid receptor (mOR) mRNA and protein in primary afferent neurons in a rat L5 spinal nerve ligation model of persistent neuropathic pain. Bilateral L4 and L5 dorsal root ganglia (DRGs), L4 and L5 spinal cord segments, and hind paw plantar skins were collected on days 0 (naïve), 3, 7, 14, and 35 post-spinal nerve ligation or post-sham surgery. We found that expression of mOR mRNA and protein in primary afferent neurons changed dynamically and site-specifically following L5 spinal nerve ligation. Real-time RT-PCR, immunohistochemistry, and Western blot analysis demonstrated a down-regulation of mOR mRNA and protein in the injured L5 DRG. In contrast, in the uninjured L4 DRG, mOR mRNA transiently decreased on day 7 and then increased significantly on day 14. Western blot analysis revealed a persistent increase in mOR protein expression, although immunohistochemistry showed no change in number of mOR-positive neurons in the uninjured L4 DRG. Interestingly, mOR protein expression was reduced in the skin on days 14 and 35 post-nerve injury and in the L4 and L5 spinal cord on day 35 post-nerve injury. These temporal and anatomically specific changes in mOR expression following nerve injury are likely to have functional consequences on pain-associated behaviors and opioid analgesia.
AB - Despite using prescribed pain medications, patients with neuropathic pain continue to experience moderate to severe pain. There is a growing recognition of a potent peripheral opioid analgesia in models of inflammatory and neuropathic pain. The goal of this study was to characterize the temporal and spatial expression of mu opioid receptor (mOR) mRNA and protein in primary afferent neurons in a rat L5 spinal nerve ligation model of persistent neuropathic pain. Bilateral L4 and L5 dorsal root ganglia (DRGs), L4 and L5 spinal cord segments, and hind paw plantar skins were collected on days 0 (naïve), 3, 7, 14, and 35 post-spinal nerve ligation or post-sham surgery. We found that expression of mOR mRNA and protein in primary afferent neurons changed dynamically and site-specifically following L5 spinal nerve ligation. Real-time RT-PCR, immunohistochemistry, and Western blot analysis demonstrated a down-regulation of mOR mRNA and protein in the injured L5 DRG. In contrast, in the uninjured L4 DRG, mOR mRNA transiently decreased on day 7 and then increased significantly on day 14. Western blot analysis revealed a persistent increase in mOR protein expression, although immunohistochemistry showed no change in number of mOR-positive neurons in the uninjured L4 DRG. Interestingly, mOR protein expression was reduced in the skin on days 14 and 35 post-nerve injury and in the L4 and L5 spinal cord on day 35 post-nerve injury. These temporal and anatomically specific changes in mOR expression following nerve injury are likely to have functional consequences on pain-associated behaviors and opioid analgesia.
KW - Dorsal root ganglion
KW - Expression
KW - Mu opioid receptors
KW - Peripheral nerve injury
KW - Skin
KW - Spinal cord
UR - http://www.scopus.com/inward/record.url?scp=79960912227&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79960912227&partnerID=8YFLogxK
U2 - 10.1016/j.ejpain.2010.11.018
DO - 10.1016/j.ejpain.2010.11.018
M3 - Article
C2 - 21310637
AN - SCOPUS:79960912227
SN - 1090-3801
VL - 15
SP - 669
EP - 675
JO - European Journal of Pain
JF - European Journal of Pain
IS - 7
ER -